More stories
Auto Physical Damage
Article
Plugged-In: EV Collision Insights 2024 Year in Review
Claims frequency for collision-damaged, repairable battery electric vehicles (BEVs) rose to 2.71% in the U.S. and 3.84% in Canada in 2024, a year-over-year increase of 38% and 34% respectively. CNBC reported that BEVs and hybrids represented 20% of all new U.S. vehicle sales in 2024, and Cox Automotive is predicting that number to climb to 25% in 2025 despite U.S. policy changes that could hinder BEV adoption.
Auto Physical Damage
Conference
CSN Collision Conference 2025
The 2025 CSN Collision Conference is an engaging and informative gathering for industry professionals.
Auto Physical Damage
Conference
NORTHEAST 2025
NORTHEAST is a premier automotive repair event designed with every industry professional in mind. With over 60,000 square feet of floor space and three days of activities, attendees will get the chance to demo a wide variety of products, attend informative seminars, and gather information on the latest procedures and processes.
Enlyte
News Release
Enlyte’s 2025 Trends Report Examines ‘The Year of Generative AI’
Industry leaders discuss impact on the growing utilization of gen AI and data analytics as well as strategies addressing clinical and auto challenges across the claims landscape.
Auto Physical Damage
Conference
Oklahoma Auto Body Association (OKABA) Trade Show 2025
The Oklahoma Auto Body Association Trade Show returns for its second year, bringing together collision repairers for an exciting two-day event.
Enlyte
Article
Ask The Pharmacist: Cosentyx and Its Place in Workers’ Comp
Are you seeing requests for Cosentyx for your injured employee but are unclear on the application of this medication? Cosentyx, a biologic medication developed by Novartis, is increasingly recognized in the treatment landscape for chronic autoimmune conditions such as plaque psoriasis, ankylosing spondylitis and psoriatic arthritis.